DUBLIN–(BUSINESS WIRE)–The “Biopreservation Market” report has been added to ResearchAndMarkets.com’s offering.
The global biopreservation market reached a value of US$ 6.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 12.1 Billion by 2027, exhibiting a CAGR of 11.9% during 2022-2027.
Companies Mentioned
- BioLife Solutions Inc.
- Thermo Fisher Scientific Inc.
- VWR International LLC
- Panasonic Corporation
- BioCision LLC
Keeping in mind the uncertainties of COVID-19, they are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor
Biopreservation refers to the use of natural or controlled antibacterial products to preserve and bank various biospecimens, such as cells, plasma, saliva, tissues, and organs, outside of its native environment. The equipment comprises freezers, refrigerators, and liquid nitrogen banks that ensures the purity and stability of the biological materials, thereby extending its shelf life.
Biopreservation exhibits non-toxic, non-immunogenic, broad bactericidal activity, and thermo-resistance properties due to which, it is being widely adopted in healthcare facilities for various clinical applications, such as storing clinical trial materials, genomics research, organ transplantation, cell-based study, and personalized medicine. Apart from this, it is also employed in the food sector to extend the shelf life of the end-product as it exploits the antimicrobial activities of pathogens on food items
The biopreservation market is majorly being driven by the growing use of biospecimens in medical research for developing novel therapies and drugs. In line with this, the rising instances of various chronic diseases, such as cancer and diabetes, degenerative conditions, and neurological disorders, are further facilitating the demand for regenerative medicine, wherein the cellular components of biopreservation are used to restore the normal functioning of damaged tissues. The increasing prevalence of biobanking is also acting as another major growth-inducing factor.
Additionally, increasing healthcare expenditure, particularly in emerging economies, along with rapid advancements in biopreservation methods and equipment are further catalyzing the market growth. Moreover, governments of various nations are implementing favorable policies and continuously investing in the research and development (R&D) activities to support stem cell therapies and enhance bio-banking and preservation standards. This, in turn, is creating a positive outlook for the market
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biopreservation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product Type
5.5 Market Breakup by Application
5.6 Market Breakup by Region
5.7 Market Forecast
5.8 SWOT Analysis
5.8.1 Overview
5.8.2 Strengths
5.8.3 Weaknesses
5.8.4 Opportunities
5.8.5 Threats
5.9 Value Chain Analysis
5.10 Porters Five Forces Analysis
5.10.1 Overview
5.10.2 Bargaining Power of Buyers
5.10.3 Bargaining Power of Suppliers
5.10.4 Degree of Competition
5.10.5 Threat of New Entrants
5.10.6 Threat of Substitutes
6 Market Breakup by Product Type
6.1 Biopreservation Equipment
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Biopreservation Media
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Therapeutic Applications
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biobank Applications
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Drug Discovery Applications
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
9 Competitive Landscape
9.1 Market Structure
9.2 Key Players
9.3 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/4yx1cy
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900